Tag
3 articles tagged Healthcare Economics.
An executive analysis of the longevity market, distinguishing between high-impact biological interventions and low-value wellness trends. The discussion highlights the economic inefficiencies of US healthcare, the rise of GLP-1s, and the critical role of social connection in health outcomes.
China has rapidly surpassed the US in clinical trial volume and novel drug approvals through targeted regulatory reforms. This analysis examines how streamlined ethics approvals, volume-based pricing negotiations, and larger trial enrollments are reshaping global biotech competition. US stakeholders must adapt regulatory frameworks and pricing strategies to maintain innovation leadership.
Analysis of January 2026 US job data showing a 130,000 job increase driven by healthcare. New research links immigration policy to a 5,000 annual reduction in elderly mortality. Prediction markets demonstrate accuracy in macroeconomic forecasting despite niche volatility.
